Acuity Law advises on the £894,000 investment in Hexigone Inhibitors Limited

Print Friendly, PDF & Email

Acuity Law advises on the £894,000 investment in Hexigone Inhibitors Limited

Key Contact: Phil Pugh

Acuity Law is pleased to have advised on the £894,000 investment in Hexigone Inhibitors Limited – an expanding corrosion technology firm based in South Wales.

Hexigone is a manufacturing start-up that offers sustainable corrosion inhibitors across the corrosion industry. Acuity Law advised Hexigone on the investment from the British Business Bank Future Fund as well as investment from new enterprise investment scheme investors and existing investors such as the Development Bank of Wales. The investment is an excellent milestone and will see the company go from strength to strength through its expansion and scale-up of its manufacturing business.

Patrick Dodds, CEO and Founder of Hexigone, commented as follows: “The Acuity team helped Hexigone from the outset of the transaction and guided the company through the different elements of the investment. Phil, Chiara and Elena were proactive and on hand to support the company throughout the process to ensure a smooth and successful completion.”

Corporate partner Phil Pugh led the transaction, with support from Chiara Howfield and Elena Visser.

If you would like any information or guidance on investment in your company, please get in touch with our Corporate Team today.

Recent Posts

Whistleblower Protection Following Nicol V World Travel And Tourism Council
May 13, 2024
To Tip Or Not To Tip? How The Employment (Allocation Of Tips) Act 2023 Will Impact The Hospitality Industry
May 13, 2024
Reform Of The Sick Note
May 13, 2024
The legal risks posed by Artificial Intelligence in the workplace
AI: An automated workforce or… a very complicated calculator?
May 1, 2024
Unlocking The CQC’s Quality Statements – How And Why “Co-Production” Must Become A Cornerstone Of Your Service
April 26, 2024
Court Of Appeal Rules On Damages Award Following A Breach By The NHS Of Its Procurement Obligations – Braceurself Limited v NHS England
April 23, 2024

Archives

Categories

Skip to content